Comprehensive Parkinson's biomarker test has prognostic and diagnostic value

First biomarker results from Parkinson's progression markers initiative detect differences in subtypes of Parkinson's disease

2013-08-27

(Press-News.org) PHILADELPHIA - Perelman School of Medicine researchers at the University of Pennsylvania report the first biomarker results reported from the Parkinson's Progression Markers Initiative (PPMI), showing that a comprehensive test of protein biomarkers in spinal fluid have prognostic and diagnostic value in early stages of Parkinson's disease. The study is reported in JAMA Neurology.

Compared to healthy adults, the study found that people with early Parkinson's had lower levels of amyloid beta, tau and alpha synuclein in their spinal fluid. In addition, those with lower concentrations of tau and alpha synuclein had greater motor dysfunction. And early Parkinson's patients with low levels of amyloid beta and tau were more likely to be classified as having the postural instability-gait disturbance- dominant (PIGD) motor type of disease, where falling, freezing, and walking difficulty are common.

"Biomarkers for Parkinson's disease such as these could help us diagnose patients earlier, and we've now shown that the simultaneous measurement of a variety of neurodegenerative disease proteins is valuable," said study senior author Leslie M. Shaw, PhD, professor of Pathology and Laboratory Medicine at Penn Medicine. Dr. Shaw and John Q. Trojanowski, MD, PhD, director of the Penn Udall Center for Parkinson's Research, are co-leaders of the Bioanalytics Core for the Parkinson's Progression Markers Initiative, an international observational clinical study sponsored by The Michael J. Fox Foundation for Parkinson's Research.

The team evaluated spinal fluid collected from baseline visits of the first 102 PPMI participants - 63 with early, untreated Parkinson's disease and 39 healthy controls. The spinal fluid was evaluated for levels of five biomarkers: amyloid beta, total tau, phosphorylated tau, alpha synuclein and the ratio of total tau to amyloid beta. Spinal fluid measures of amyloid and tau are currently used in research to distinguish Alzheimer's disease from other neurodegenerative diseases. In contrast to Alzheimer's, where tau levels are higher than healthy controls, the study found that early Parkinson's patients had lower levels of tau than healthy controls. One reason, researchers suggest, could be that interactions between tau and alpha synuclein may limit the release of tau into the cerebrospinal fluid of Parkinson's patients.

"Through PPMI, we are hoping to identify subgroups of Parkinson's patients whose disease is likely to progress at a different rate, as early as possible," said Dr. Trojanowski. "Early prediction is critical, for both motor and dementia symptoms."

The Parkinson's PIGD motor subtype has been associated with a more rapid cognitive decline as well as greater functional disability. Using the biomarker test, this initial study found that levels of all spinal fluid biomarkers were lower in the PIGD motor subtype than other types of PD as well as healthy controls. In addition, amyloid beta and phosphorylated tau were at lower levels in the PIGD motor subtype, but were no different in tremor or indeterminate subtypes compared to normal controls.

This spinal fluid testing procedure is only being used in research studies, and will be continued to be evaluated and validated in a larger study of the PPMI cohorts.

In addition to leading the Bioanalytics Core of PPMI, Penn's Parkinson's Disease and Movement Disorders Center is one of the two dozen trial sites where volunteers are evaluated throughout the PPMI study. The Penn PDMDC has been part of the PPMI group studying people with early Parkinson's disease as well as healthy adults since 2010, and began enrollment for a new, pre-symptomatic arm of the study in the summer of 2013. The pre-motor arm of PPMI is enrolling participants who do not have Parkinson's disease and are living with one of three potential risk factors for PD: a reduced sense of smell (hyposmia); rapid eye movement sleep behavior disorder (RBD; a disorder in which the individual acts out his/her dreams); or a mutation in the LRRK2 gene (the single greatest genetic contributor to PD known to date).

"In addition to biomarker tests, validating risk factors could enable earlier detection of the disease and open new avenues in the quest for therapies that could slow or stop disease progression," said PPMI trial site study leader Matthew Stern, MD, professor of Neurology and director of Penn's Parkinson's Disease and Movement Disorders Center.

### Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 16 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $398 million awarded in the 2012 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital — the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2012, Penn Medicine provided $827 million to benefit our community.

ELSE PRESS RELEASES FROM THIS DATE:

Terminology used to describe preinvasive breast cancer may affect patients' treatment preferences

2013-08-27

When ductal carcinoma in situ (DCIS, a preinvasive malignancy of the breast) is described as a high-risk condition rather than cancer, more women report that they would opt for nonsurgical treatments, according to a research letter by Zehra B. Omer, B.A., of Massachusetts General Hospital—Institute for Technology Assessment, Boston, and colleagues. A total of 394 healthy women without a history of breast cancer participated in the study and were presented with three scenarios that described a diagnosis of DCIS as noninvasive breast cancer, breast lesion, or abnormal cells. ...

Intervention appears effective to prevent weight gain among black women

2013-08-27

An intervention not focused on weight loss was effective for weight gain prevention among socioeconomically disadvantaged black women, according to a report published by JAMA Internal Medicine, a JAMA Network publication. Promoting clinically meaningful weight loss among black women has been a challenge. Compared to white women, "black women have higher rates of body weight satisfaction, fewer social pressures to lose weight, and sociocultural norms that tolerate heavier body weights," according to the study background. "New weight management strategies are necessary ...

Thyroid ultrasound imaging may be useful to reduce biopsies in patients with low risk of cancer

2013-08-27

Thyroid ultrasound imaging could be used to identify patients who have a low risk of cancer for whom biopsy could be postponed, according to a study by Rebecca Smith-Bindman, M.D., of the University of California, San Francisco, and colleagues. The retrospective case-control study of 8,806 patients who underwent 11,618 thyroid ultrasound imaging examinations from January 2000 through March 2005 included 105 patients diagnosed as having thyroid cancer. Thyroid nodules were common in patients diagnosed as having cancer (96.9 percent) and patients not diagnosed as having ...

Extremely preterm infants and risk of developing neurodevelopmental impairment later in childhood

2013-08-27

A meta-analysis of previously reported studies by Gregory P. Moore, M.D., F.R.C.P.C., of The Ottawa Hospital, Ontario, Canada, and colleagues examined the rate of moderate to severe and severe neurodevelopmental impairment by gestational age in extremely preterm survivors followed up between ages 4 and 8 years, and determined whether there is a significant difference in impairment rates between the successive weeks of gestation of survivors. The search of English-language publications found nine studies that met inclusion criteria of being published after 2004, a prospective ...

Interpretation of do-not-resuscitate order appears to vary among pediatric physicians

2013-08-27

Clinicians use the do-not-resuscitate (DNR) order not only as a guide for therapeutic decisions during a cardiopulmonary arrest but also as a surrogate for broader treatment directives, according to a study by Amy Sanderson M.D., of Boston Children's Hospital, M.A., and colleagues. A total of 107 physicians and 159 nurses responded to a survey regarding their attitudes and behaviors about DNR orders for pediatric patients. There was substantial variability in the interpretation of the DNR order. Most clinicians (66.9 percent) reported that they considered that a DNR order ...

Genome-wide survey examines recessive alzheimer disease gene

2013-08-27

Runs of homozygosity (ROHs, regions of the genome where the copies inherited from parents are identical) may contribute to the etiology (origin) of Alzheimer disease (AD), according to a study by Mahdi Ghani, Ph.D., of the University of Toronto, Ontario, Canada, and colleagues. Caribbean Hispanics are known to have an elevated risk for AD and tend to have large families with evidence of inbreeding, according to the study background. A Caribbean Hispanic data set of 547 unrelated cases (48.8 percent with familial AD) and 542 controls collected from a population known ...

Study examines cerebrospinal fluid biomarkers in early Parkinson disease

2013-08-27

Cerebrospinal fluid (CSF) levels of tau proteins, ɑ-synuclein, and β-amyloid 1-42 (Αβ1-42) appear to be associated with early stage Parkinson disease (PD) in a group of untreated patients compared with healthy patients, according to a study by Ju-Hee Kang, M.D., of the University of Pennsylvania, and colleagues. The study included the initial 102 research volunteers (63 patients with PD and 39 healthy control patients) of the Parkinson's Progression Markers Initiative (PPMI) study. Results indicate that slightly, but significantly, lower levels of ...

Thyroid cancer biopsy guidelines should be simplified, researchers say

2013-08-27

A team led by UC San Francisco researchers has called for simplified guidelines on when to biopsy thyroid nodules for cancer, which they say would result in fewer unnecessary biopsies. Their recommendation, based on a retrospective study published online on August 26, 2013 in JAMA Internal Medicine, is to biopsy patients only when imaging reveals a thyroid nodule with microcalcifications – tiny flecks of calcium – or one that is over two centimeters in diameter and completely solid. Any other findings represent too low a risk to require biopsy or continued surveillance ...

Touch and movement neurons shape the brain's internal image of the body

2013-08-27

DURHAM, N.C. -- The brain's tactile and motor neurons, which perceive touch and control movement, may also respond to visual cues, according to researchers at Duke Medicine. The study in monkeys, which appears online Aug. 26, 2013, in the journal Proceedings of the National Academy of Sciences, provides new information on how different areas of the brain may work together in continuously shaping the brain's internal image of the body, also known as the body schema. The findings have implications for paralyzed individuals using neuroprosthetic limbs, since they suggest ...

Even mild stress can make it difficult to control your emotions, NYU researchers find

2013-08-27

Even mild stress can thwart therapeutic measures to control emotions, a team of neuroscientists at New York University has found. Their findings, which appear in the journal Proceedings of the National Academy of Sciences, point to the limits of clinical techniques while also shedding new light on the barriers that must be overcome in addressing afflictions such as fear or anxiety. "We have long suspected that stress can impair our ability to control our emotions, but this is the first study to document how even mild stress can undercut therapies designed to keep our ...

Comprehensive Parkinson's biomarker test has prognostic and diagnostic value

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: